- JP-listed companies
- CanBas Co.,Ltd.
- Cash flow
CanBas Co.,Ltd. (4575) Cash flow
Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
| 2014/06 | 2015/06 | 2016/06 | 2017/06 | 2018/06 | 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Depreciation & amortization | 15 | 13 | 11 | 7 | - | - | - | - | - | - | - | - |
| Cash from operations | -250 | -310 | -417 | -313 | -429 | -384 | -553 | -689 | -720 | -1,399 | -1,280 | -771 |
| Capital expenditures | -1 | -1 | -13 | - | - | - | - | - | - | - | - | - |
| Cash from investing | -2 | -1 | -13 | -0 | -0 | - | -0 | - | 0 | - | - | 0 |
| Repurchases of common stock | - | - | - | - | - | - | -0 | - | - | -0 | -0 | - |
| Cash from financing | 110 | 856 | 375 | 381 | 8 | 683 | 902 | 729 | 283 | 2,273 | 1,538 | 1,749 |
| Free cash flow | - | - | - | - | - | - | - | - | - | |||
| FCF margin (%) | - | - | - | - | - | - | - | - | - | - |